The National Agency for Food and Drug Administration and Control (NAFDAC) on Monday alerted Nigerians on the circulation of falsified chloroquine phosphate 250mg tablets.
In a statement the Director-General of the agency, Prof Mojisola Adeyeye, said the NAFDAC was notified by the World Health Organisation (WHO) of the circulation of the tablets in Cameroon.
“The falsified chloroquine phosphate 250mg tablets were manufactured by Jiangsu pharmaceutical Inc, Astral pharmaceutical New Bhupalpura, China.
“The tablets manufactured by these companies has no Active Pharmaceutical Ingredient (API) and are in packs of 1000 tablets.
“The use of the falsified chloroquine phosphate 250mg tablets may result in treatment failure and could even cause death,” she warned.